Clinical Trials on Hypoactive Delirium in Ireland

Total 7 results

BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
Palatin Technologies, Inc
AMAG Pharmaceuticals, Inc.

Completed

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
Palatin Technologies, Inc

Completed

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
Palatin Technologies, Inc

Completed

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Hypoactive Sexual Desire Disorder | Female Sexual Arousal Disorder

United States, Canada
Rhode Island Hospital

Completed

The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU

Delirium

United States

3

Subscribe